FDA Inspection 1202396 — Abbott GmbH

Abbott GmbH — FEI 3002809144

The FDA completed an inspection of Abbott GmbH on January 17, 2023 in Wiesbaden. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 17, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Wiesbaden (Germany)